TG Therapeutics, led by its CEO, is at the forefront of developing treatments for multiple sclerosis. With recent developments in TGTX stock, shareholders are closely watching the market. Class action lawsuits and stock price predictions add to the buzz. Stay tuned for breaking news and updates on TG Therapeutics and its innovative therapeutics.